Pharmaceutical Risk-Sharing Arrangements Can Reduce Drug Costs for Payers

from ISPOR News & Press Releases at http://bit.ly/2HElUHm on March 25, 2019 at 07:32AM Study in Non–Small Cell Lung Cancer Using Real-World Data Lawrenceville, NJ, USA—March 25, 2019—Value in Health, the official journal of ISPOR—the professional society for health economics and outcomes research, announced today the publication of new research showing that pharmaceutical risk-sharing arrangements […]

Identification, Review and Use of Health State Utilities in Cost-Effectiveness Models: An ISPOR Good Practices for Outcomes Research Task Force Report

from Health Economics and Decision Science Blog @ ScHARR at http://bit.ly/2ushTNu on March 25, 2019 at 07:00AM ISPOR  HEDS colleagues – involved in the Task Force on using utlities in cost effectiveness models – have contributed to a ISPOR report Identification, Review and Use of Health State Utilities in Cost-Effectiveness Models: An ISPOR Good Practices for Outcomes Research […]